Pancreatic Disorders

Dear Member of the Pancreatic Disorders Section and interested others:

Thank you making our sessions at the 41st annual DDW® in New Orleans, LA scientifically relevant and exciting! If you have specific feedback regarding speakers sponsored by the Pancreatic Disorders (PAN) Section at DDW, please share your thoughts with us. We will do our best to consider your comments and concerns as we plan our program for next DDW 2011 in Chicago.

This year the PAN section accepted the majority of the abstracts submitted. The accepted abstracts were designated as oral or poster presentations and of distinction based on their ranking by our dedicated abstract reviewers.

PAN Abstract Selection 2010
Total Abstracts submitted 164
Accepted Abstracts 149
Oral Presentations 29
Posters 120
Posters of Distinction 19

PAN sponsored Clinical, Translational, and Research Symposia, and abstract based Research and Topic Fora, as well as one Distinguished Abstract Plenary and one SOA Lecture.

PAN Sessions
Sunday, May 2, 2010 Attendance
Topic Forum: Cystic and Solid Pancreatic Neoplasms 8:30am-10:00am 125
SOA Lecture: Smoking and Other Environmental Factors in Pancreatitis 10:30am-11:30am 75
Research Symposium: Development of Pancreatic Cancer 2:15pm-3:45pm 75
Monday, May 3, 2010
Clinical Symposium: Severe and Necrotizing Pancreatitis 2:15pm-3:45pm 310
Pancreatic Disorders Distinguished Abstract Plenary 4:00pm-5:30pm 100
Pancreatic Disorders Section Business Meeting 5:30pm-6:30pm unknown
Tuesday, May 4, 2010
Clinical Symposium: Pain and Chronic Pancreatitis 8:30am-10:00am 105
Translational Symposium: The Basis and Basics of Pancreatic Function Testing 10:30am-12:00pm 175
Research Forum: Clinical Pancreatitis 2:15pm-3:45pm 70
Research Forum: Mechanisms of Pancreatitis 4:00pm-5:30pm 40
Wednesday, May 5, 2010
Research Forum: Pancreatic Biology and Pathobiology 10:30am-12:00pm 30

Each June, PAN section descriptors are reviewed to optimize scientific relevance and minimize overlapping topics with other AGA Institute Sections and to encourage both clinical research and basic science abstract submissions. The current list of abstract descriptors is as follows. (These are the same PAN descriptors that we anticipate using for DDW 2011.) We would like to thank our abstract review Committee Chairs and members for generously sharing their expertise and time in order to ensure that the most novel and relevant developments in Pancreatic Disorders were shared at DDW.

Descriptor Name Abstracts Received Abstract Review Chair Abstract Reviewers
Experimental Acute Pancreatitis 11 Edwin Thrower Steven Pandol, Markus Lerch, Steven Vigna
Experimental Fibrogenesis and Chronic Pancreatitis 9 Edwin Thrower Steven Pandol, Markus Lerch, Steven Vigna
Pancreatic Physiology and Basic Pancreatic Biology 17 Miklos Sahin-Toth Baoan Ji, Guy Groblewski, David Whitcomb
Genetic Basis of Pancreatic Disease 12 Miklos Sahin-Toth Baoan Ji, Guy Groblewski, David Whitcomb
Clinical Acute Pancreatitis 29 James Grendell John Lieb, Santhi Vege, Bechien Wu
Clinical Chronic Pancreatitis 40 James Grendell John Lieb, Santhi Vege, Bechien Wu
Pancreatic Cancer: Risk Factors and Diagnosis 26 Massimo Raimondo Luca Frulloni, Sanjay Jagannath, Michael Kaheleh
Pancreatic Cystic Neoplasms and IPMN 20 Massimo Raimondo Luca Frulloni, Sanjay Jagannath, Michael Kaheleh

Section leaders will review committee membership this summer for abstract review committees to confirm the final composition for DDW 2011 committees.

PAN section members interested in serving in this capacity are encouraged to contact us and volunteer to review abstracts.

Please submit your invaluable ideas about the topics and invited speakers that you would like to hear at next year's DDW. The more specific you can be, the better (title, individual talks, speakers, learning objectives). Please forward your suggestions to John Whiton, AGA Institute by July 6, 2010.

Members interested in participating in the various activities of the Section should contact us at the addresses below. We are particularly interested in increasing participation by junior investigators/clinicians and international members at this time.

Thank you for your continuing strong support of the Pancreatic Disorders Section.

Sincerely,

Rodger A. Liddle, MD
Chair, PAN Section, AGA Institute Council

Chris E. Forsmark, MD, AGAF
Vice-Chair, PAN Section, AGA Institute Council